Cells with a familial Alzheimerʼs disease mutation produce authentic β-peptide

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · see citing works

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp ₇₁₇ ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471 · see citing works

Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., Andrieu, P. D. S. I., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E. G., Holsztynska, E. J., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00012.x · Cited by 870 · see citing works

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · see citing works

Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 833 · see citing works

Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain

Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7013 · Cited by 676 · see citing works

Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay

Ida, N., Hartmann, T., Pantel, J., Schrüder, J., Zerfaß, R., Fürstl, H., Sandbrink, R., Masters, C. L., & Beyreuther, K. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22908 · Cited by 476 · see citing works

Cellular mechanisms of β-amyloid production and secretion

Sinha, S., & Lieberburg, I. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11049 · Cited by 438 · see citing works

Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome

Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 380 · see citing works

Aggregation of Secreted Amyloid β-Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture

Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydel, R. E., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9564 · Cited by 364 · see citing works

Amyloid β-Peptide Is Transported on Lipoproteins and Albumin in Human Plasma

Biere, A. L., Ostaszewski, B., Stimson, E. R., Hyman, B. T., Maggio, J. E., & Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32916 · Cited by 331 · see citing works

Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid

Vigo‐Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., & Schenk, D. B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09841.x · Cited by 385 · see citing works

Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor

Haass, C., Hung, A. Y., Selkoe, D. J., & Teplow, D. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32503-6 · Cited by 315 · see citing works

Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities

Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P. A., & Selkoe, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13170 · Cited by 287 · see citing works

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Citron, M., Vigo-Pelfrey, C., Teplow, D. B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L., & Selkoe, D. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11993 · Cited by 366 · see citing works

Exploring the Etiology of Alzheimer Disease Using Molecular Genetics

Lendon, C. L. (1997) · JAMA · doi:10.1001/jama.1997.03540340059034 · Cited by 272 · see citing works

Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.

Iwatsubo, T., Saido, T. C., Mann, D. M. A., Lee, V. M.-Y., & Trojanowski, J. Q. (1996) · Europe PMC (PubMed Central) · Cited by 248 · see citing works

The role of Aβ42 in Alzheimer's disease

Younkin, S. G. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80035-1 · Cited by 282 · see citing works

Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease

Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., & Ball, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78080-6 · Cited by 223 · see citing works

Uptake, Degradation, and Release of Fibrillar and Soluble Forms of Alzheimer's Amyloid β-Peptide by Microglial Cells

Chung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212 · see citing works

Effects of in vivo conditions on amyloid aggregation

Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 179 · see citing works

The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase Activities

Klafki, H., Abramowski, D., Swoboda, R., Paganetti, P., & Staufenbiel, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28655 · Cited by 159 · see citing works

Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease

Geller, L. N., & Potter, H. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0236 · Cited by 146 · see citing works

Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells.

Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., & Suzuki, N. (1995) · Biochemistry · doi:10.1021/bi00032a022 · Cited by 153 · see citing works

Presenilin function and γ‐secretase activity

Brunkan, A. L., & Goate, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03099.x · Cited by 144 · see citing works

Cell-type and Amyloid Precursor Protein-type Specific Inhibition of Aβ Release by Bafilomycin A1, a Selective Inhibitor of Vacuolar ATPases

Knops, J., Suomensaari, S., Lee, M., McConlogue, L., Seubert, P. A., & Sinha, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2419 · Cited by 115 · see citing works

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Lacosta, A.-M., Pascual-Lucas, M., Pesini, P., Casabona, D., Pérez-Grijalba, V., Marcos-Campos, I., Sarasa, L., Canudas, J., Badi, H., Monleón, I., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0340-8 · Cited by 111 · see citing works

Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain

Shin, R., Ogino, K., Kondo, A., Saido, T. C., Trojanowski, J. Q., Kitamoto, T., & Tateishi, J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08187.1997 · Cited by 96 · see citing works

In Silico Discovery of β-Secretase Inhibitors

Danzhi Huang, A., Lüthi, U., Kolb, P., Cecchini, M., Barberis, A., & Caflisch, A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0573108 · Cited by 83 · see citing works

Polyclonals to β-amyloid(1–42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum

Mak, K., Yang, F., Vinters, H. V., Frautschy, S. A., & Cole, G. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91725-6 · Cited by 80 · see citing works

Fine mapping of the -T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

Ertekin-Taner, N. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg343 · Cited by 80 · see citing works

Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides

Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108 · see citing works

Discovery of Cell-Permeable Non-Peptide Inhibitors of β-Secretase by High-Throughput Docking and Continuum Electrostatics Calculations

Danzhi Huang, A., Lüthi, U., Kolb, P., Edler, K., Cecchini, M., Audetat, S., Barberis, A., & Caflisch, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050499d · Cited by 80 · see citing works

Design and Synthesis of Statine-Based Cell-Permeable Peptidomimetic Inhibitors of Human β-Secretase

Hom, R. K., Fang, L. Y., Mamo, S., Tung, J. S., Guinn, A. C., Walker, D., Davis, D. L., Gailunas, A. F., Thorsett, E. D., Sinha, S., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025619l · Cited by 78 · see citing works

Picomolar Amyloid-β Peptides Enhance Spontaneous Astrocyte Calcium Transients

Lee, L., Kosuri, P., & Arancio, O. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130740 · Cited by 73 · see citing works

Magnetic Resonance Spectroscopic Changes in Alzheimer's Diseasea

Pettegrew, J. W., Klunk, W. E., Panchalingam, K., McCLURE, R. J., & Stanley, J. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48480.x · Cited by 58 · see citing works

Effects of the amyloid precursor protein Glu693→Gln ‘Dutch’ mutation on the production and stability of amyloid β-protein

Watson, D. J., Selkoe, D. J., & Teplow, D. B. (1999) · Biochemical Journal · doi:10.1042/bj3400703 · Cited by 57 · see citing works

Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders

Suh, J., Kim, M., Yoo, J., Han, J., Paulina, C., & Lim, M. H. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214978 · Cited by 48 · see citing works

APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology

Greenberg, B., Savage, M. J., Howland, D., Ali, S. M., Siedlak, S. L., Perry, G. L., Siman, R., & Scott, R. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00001-2 · Cited by 45 · see citing works

Short‐term exposure to constant light promotes strong circadian phase‐resetting responses to nonphotic stimuli in Syrian hamsters

Knoch, M. E., Gobes, S. M. H., Pavlovska, I., Su, C., Mistlberger, R. E., & Glass, J. D. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03371.x · Cited by 45 · see citing works

Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer’s disease

Wirths, O., & Zampar, S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702972 · Cited by 44 · see citing works

Alzheimer’s Disease: Drug Discovery

Huang, X. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020 · Cited by 45 · see citing works

The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease

Hendriks, L., & Broeckhoven, C. V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0006n.x · Cited by 41 · see citing works

Controlling amyloid growth in multiple dimensions

Dong, J., Lu, K., Lakdawala, A. S., Mehta, A. K., & Lynn, D. G. (2006) · Amyloid · doi:10.1080/13506120600960809 · Cited by 41 · see citing works

Secretases as therapeutic targets for the treatment of Alzheimer's disease

Dominguez, D. I., Strooper, B. D., & Annaert, W. G. (2001) · Amyloid · doi:10.3109/13506120109007356 · Cited by 33 · see citing works

Dorothy Russell Memorial Lecture The molecular pathology of Alzheimer's disease: are we any closer to understanding the neurodegenerative process?

Smith, C. J., & Anderton, B. H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00977.x · Cited by 27 · see citing works

Electrophoretic mobility of Alzheimer’s amyloid-β peptides in urea–sodium dodecyl sulfate–polyacrylamide gel electrophoresis

Kawooya, J. K., Emmons, T. L., Gonzalez‐DeWhitt, P. A., Camp, M. C., & D’Andrea, S. C. (2003) · Analytical Biochemistry · doi:10.1016/j.ab.2003.08.027 · Cited by 26 · see citing works

The COOH-terminus of the Alzheimer amyloid Aβ peptide: Differences in length influence the process of amyloid deposition in Alzheimer brain, and tell us something about relationships among parenchymal and vessel-associated amyloid deposits

Greenberg, B. (1995) · Amyloid · doi:10.3109/13506129509036927 · Cited by 25 · see citing works

Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats.

Takahashi, H., Fukumoto, H., Maeda, R., Terauchi, J., Kato, K., & Miyamoto, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.032 · Cited by 24 · see citing works

Secretory cleavage site of Alzheimer amyloid precursor protein is heterogeneous in Down's syndrome brain

Kametania, F., Tanaka, K., Tokuda, T., & Ikeda, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00851-5 · Cited by 20 · see citing works

Molecular Pathology of Alzheimer's Disease

Castellani, R. J., & Perry, G. L. (2013) · Colloquium Series on Neurobiology of Alzheimer s Disease · doi:10.4199/c00095ed1v01y201310alz001 · Cited by 19 · see citing works

Is pharmacological prevention of Alzheimer's a realistic goal?

Anthony, J. C., Breitner, J. C. S., & Zandi, P. P. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.4.365 · Cited by 18 · see citing works

Secretases as targets for drug design in Alzheimer’s disease

Hendriksen, J. V. R. B., Nottet, H. S. L. M., & Smits, H. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00937.x · Cited by 17 · see citing works

Immunotherapy Targeting Amyloid-ß Peptides in Alzheimer’s Disease

Zampar, S., & Wirths, O. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch2 · Cited by 17 · see citing works

The APP and PS1/2 Mutations Linked to Early Onset Familial Alzheimer’s Disease Increase the Extracellular Concentration of Aβ1–42(43)

Younkin, S. G. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_4 · Cited by 15 · see citing works

Aβ8-20 Fragment as an Anti-Fibrillogenic and Neuroprotective Agent: Advancing toward Efficient Alzheimer’s Disease Treatment

Zimbone, S., Giuffrida, M. L., Sabatino, G., Natale, G. D., Tosto, R., Consoli, G. M. L., Milardi, D., Pappalardo, G., & Sciacca, M. F. M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00720 · Cited by 15 · see citing works

Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice

Ali, S. M., Siedlak, S. L., Gonzalez‐DeWhitt, P. A., Altman, R. A., Glendening, J. M., Lowery, D. E., Savage, M. J., Polities, H. G., Perry, G. L., & Greenberg, B. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02065-9 · Cited by 8 · see citing works

Strategic Thoughts on the Alzheimer’s Disease Amyloid Protein Precursor: The Way Forward

Masters, C. L., & Beyreuther, K. T. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_1 · Cited by 7 · see citing works

Carboxy‐terminal truncation of long‐tailed amyloid β‐peptide is inhibited by serine protease inhibitor and peptide aldehyde

Hamazaki, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00157-4 · Cited by 6 · see citing works

Alzheimer’s Disease and Hemorrhagic Stroke: Their Relationship to βA4 Amyloid Deposition

Hendriks, L., Cras, P. P., Martin, J., & Broeckhoven, C. V. (1995) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-79423-0_4 · Cited by 5 · see citing works

Overexpression of a COOH-terminal fragment of β-amyloid precursor protein in HeLa cells results in accumulation in a pre-Golgi compartment and generation of an Aβ-like fragment

Kuentzel, S. L., Gonzalez‐DeWhitt, P. A., Lowery, D. E., Altman, R. A., Leone, J. W., Heinrikson, R. L., Greenberg, B., & Raub, T. J. (1996) · Amyloid · doi:10.3109/13506129609014360 · Cited by 4 · see citing works

The metabolism of the amyloid precursor protein and its relevance to Alzheimer's disease

Sinha, S. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02172030 · Cited by 1 · see citing works

Structural and Toxic Properties of Protein Aggregates: Towards a Molecular Understanding of Alzheimer's Disease

Wang, L., & Campioni, S. (2011) · InTech eBooks · doi:10.5772/20922

Molecular and cell biological aspects of Alzheimer's ß-amyloid precursor and related proteins

van den Hurk, W. H. (2001) · Radboud Repository (Radboud University)

Pathological Changes in the Elderly Human Brain

Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_2

Etiological Considerations

Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_4

Alzheimer’s Disease

Siman, R., & Greenberg, B. (1996) · Humana Press eBooks · doi:10.1007/978-1-59259-466-5_10

N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks

Zampar, S. (2021) · doi:10.53846/goediss-9004

GXGD-Type Intramembrane Proteases

Steiner, H., & Haass, C. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6311-4_3

BindingDB Entry 50013173: Design and synthesis of statine-based cell-permeable peptidomimetic inhibitors of human beta-secretase.

BindingDB (2009) · UC San Diego · doi:10.7270/q2zg6rmk

BindingDB Entry 50016625: Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculations.

BindingDB (2009) · UC San Diego · doi:10.7270/q228074p

Time-Dependent Psychotropic Drug Effects

Nagayama, H., Cornélissen, G., Pandi-Perumal, S. R., & Franz Halberg, A. (2006) · Springer eBooks · doi:10.1007/0-387-27682-3_7

Production of Amyloid β Protein from Normal Amyloid β‐Protein Precursor (βAPP) and the Mutated βAPPS Linked to Familial Alzheimer's Diseasea

Golde, T. E., Cai, X.-D., Shoji, M., & Younkin, S. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23036.x · Cited by 34 · see citing works

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · see citing works

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · see citing works

Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor

Cai, X.-D., Golde, T. E., & Younkin, S. G. (1993) · Science · doi:10.1126/science.8424174 · Cited by 913 · see citing works

The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer’s Disease in SH-SY5Y cells

Guyon, A., Rousseau, J., Lamothe, G., & Tremblay, J. P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237122 · Cited by 20 · see citing works